3.26.1 html 156 213 1 false 42 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.compasstherapeutics.com/20260331/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.compasstherapeutics.com/20260331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.compasstherapeutics.com/20260331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://www.compasstherapeutics.com/20260331/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://www.compasstherapeutics.com/20260331/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.compasstherapeutics.com/20260331/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Nature of Business and Basis of Presentation Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-1-nature-of-business-and-basis-of-presentation Note 1 - Nature of Business and Basis of Presentation Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Fair Value Measurements Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-3-fair-value-measurements Note 3 - Fair Value Measurements Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Marketable Securities Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-4-marketable-securities Note 4 - Marketable Securities Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Property and Equipment Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-5-property-and-equipment Note 5 - Property and Equipment Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Accrued Expenses Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-6-accrued-expenses Note 6 - Accrued Expenses Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Commitments and Contingencies Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-7-commitments-and-contingencies Note 7 - Commitments and Contingencies Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Stock-based Compensation Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-8-stockbased-compensation Note 8 - Stock-based Compensation Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Stockholders' Equity Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-9-stockholders-equity Note 9 - Stockholders' Equity Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Basic and Diluted Net Loss Per Share Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-10-basic-and-diluted-net-loss-per-share Note 10 - Basic and Diluted Net Loss Per Share Notes 16 false false R17.htm 016 - Disclosure - Note 11 - License, Research and Collaboration Agreements Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-11-license-research-and-collaboration-agreements Note 11 - License, Research and Collaboration Agreements Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Segment Information Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-12-segment-information- Note 12 - Segment Information Notes 18 false false R19.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 19 false false R20.htm 995445 - Disclosure - Note 3 - Fair Value Measurements (Tables) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-3-fair-value-measurements-tables Note 3 - Fair Value Measurements (Tables) Tables http://www.compasstherapeutics.com/20260331/role/statement-note-3-fair-value-measurements 20 false false R21.htm 995446 - Disclosure - Note 4 - Marketable Securities (Tables) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-4-marketable-securities-tables Note 4 - Marketable Securities (Tables) Tables http://www.compasstherapeutics.com/20260331/role/statement-note-4-marketable-securities 21 false false R22.htm 995447 - Disclosure - Note 5 - Property and Equipment (Tables) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-5-property-and-equipment-tables Note 5 - Property and Equipment (Tables) Tables http://www.compasstherapeutics.com/20260331/role/statement-note-5-property-and-equipment 22 false false R23.htm 995448 - Disclosure - Note 6 - Accrued Expenses (Tables) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-6-accrued-expenses-tables Note 6 - Accrued Expenses (Tables) Tables http://www.compasstherapeutics.com/20260331/role/statement-note-6-accrued-expenses 23 false false R24.htm 995449 - Disclosure - Note 7 - Commitments and Contingencies (Tables) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-7-commitments-and-contingencies-tables Note 7 - Commitments and Contingencies (Tables) Tables http://www.compasstherapeutics.com/20260331/role/statement-note-7-commitments-and-contingencies 24 false false R25.htm 995450 - Disclosure - Note 8 - Stock-based Compensation (Tables) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-8-stockbased-compensation-tables Note 8 - Stock-based Compensation (Tables) Tables http://www.compasstherapeutics.com/20260331/role/statement-note-8-stockbased-compensation 25 false false R26.htm 995451 - Disclosure - Note 10 - Basic and Diluted Net Loss Per Share (Tables) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-10-basic-and-diluted-net-loss-per-share-tables Note 10 - Basic and Diluted Net Loss Per Share (Tables) Tables http://www.compasstherapeutics.com/20260331/role/statement-note-10-basic-and-diluted-net-loss-per-share 26 false false R27.htm 995452 - Disclosure - Note 12 - Segment Information (Tables) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-12-segment-information-tables Note 12 - Segment Information (Tables) Tables http://www.compasstherapeutics.com/20260331/role/statement-note-12-segment-information- 27 false false R28.htm 995453 - Disclosure - Note 1 - Nature of Business and Basis of Presentation (Details Textual) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-1-nature-of-business-and-basis-of-presentation-details-textual Note 1 - Nature of Business and Basis of Presentation (Details Textual) Details http://www.compasstherapeutics.com/20260331/role/statement-note-1-nature-of-business-and-basis-of-presentation 28 false false R29.htm 995454 - Disclosure - Note 3 - Fair Value Measurements - Financial Assets Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-3-fair-value-measurements-financial-assets-measured-at-fair-value-on-a-recurring-basis-details Note 3 - Fair Value Measurements - Financial Assets Measured at Fair Value on a Recurring Basis (Details) Details 29 false false R30.htm 995455 - Disclosure - Note 4 - Marketable Securities - Marketable Securities (Details) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-4-marketable-securities-marketable-securities-details Note 4 - Marketable Securities - Marketable Securities (Details) Details 30 false false R31.htm 995456 - Disclosure - Note 4 - Marketable Securities - Maturity (Details) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-4-marketable-securities-maturity-details Note 4 - Marketable Securities - Maturity (Details) Details 31 false false R32.htm 995457 - Disclosure - Note 5 - Property and Equipment (Details Textual) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-5-property-and-equipment-details-textual Note 5 - Property and Equipment (Details Textual) Details http://www.compasstherapeutics.com/20260331/role/statement-note-5-property-and-equipment-tables 32 false false R33.htm 995458 - Disclosure - Note 5 - Property and Equipment - Schedule of Property and Equipment (Details) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-5-property-and-equipment-schedule-of-property-and-equipment-details Note 5 - Property and Equipment - Schedule of Property and Equipment (Details) Details 33 false false R34.htm 995459 - Disclosure - Note 6 - Accrued Expenses (Details Textual) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-6-accrued-expenses-details-textual Note 6 - Accrued Expenses (Details Textual) Details http://www.compasstherapeutics.com/20260331/role/statement-note-6-accrued-expenses-tables 34 false false R35.htm 995460 - Disclosure - Note 6 - Accrued Expenses - Schedule of Accrued Expenses (Details) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-6-accrued-expenses-schedule-of-accrued-expenses-details Note 6 - Accrued Expenses - Schedule of Accrued Expenses (Details) Details 35 false false R36.htm 995461 - Disclosure - Note 7 - Commitments and Contingencies (Details Textual) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-7-commitments-and-contingencies-details-textual Note 7 - Commitments and Contingencies (Details Textual) Details http://www.compasstherapeutics.com/20260331/role/statement-note-7-commitments-and-contingencies-tables 36 false false R37.htm 995462 - Disclosure - Note 7 - Commitments and Contingencies - Undiscounted Cash Flows Reconciled to Operating Lease Liabilities (Details) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-7-commitments-and-contingencies-undiscounted-cash-flows-reconciled-to-operating-lease-liabilities-details Note 7 - Commitments and Contingencies - Undiscounted Cash Flows Reconciled to Operating Lease Liabilities (Details) Details 37 false false R38.htm 995463 - Disclosure - Note 8 - Stock-based Compensation (Details Textual) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-8-stockbased-compensation-details-textual Note 8 - Stock-based Compensation (Details Textual) Details http://www.compasstherapeutics.com/20260331/role/statement-note-8-stockbased-compensation-tables 38 false false R39.htm 995464 - Disclosure - Note 8 - Stock-based Compensation - Stock-based Compensation Expense (Details) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-8-stockbased-compensation-stockbased-compensation-expense-details Note 8 - Stock-based Compensation - Stock-based Compensation Expense (Details) Details 39 false false R40.htm 995465 - Disclosure - Note 8 - Stock-based Compensation - Summary of Stock Option Activity (Details) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-8-stockbased-compensation-summary-of-stock-option-activity-details Note 8 - Stock-based Compensation - Summary of Stock Option Activity (Details) Details 40 false false R41.htm 995466 - Disclosure - Note 8 - Stock-based Compensation - Weighted Average Assumptions (Details) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-8-stockbased-compensation-weighted-average-assumptions-details Note 8 - Stock-based Compensation - Weighted Average Assumptions (Details) Details 41 false false R42.htm 995467 - Disclosure - Note 8 - Stock-based Compensation - Summary of RSU Activity (Details) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-8-stockbased-compensation-summary-of-rsu-activity-details Note 8 - Stock-based Compensation - Summary of RSU Activity (Details) Details 42 false false R43.htm 995468 - Disclosure - Note 9 - Stockholders' Equity (Details Textual) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-9-stockholders-equity-details-textual Note 9 - Stockholders' Equity (Details Textual) Details http://www.compasstherapeutics.com/20260331/role/statement-note-9-stockholders-equity 43 false false R44.htm 995469 - Disclosure - Note 10 - Basic and Diluted Net Loss Per Share (Details Textual) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-10-basic-and-diluted-net-loss-per-share-details-textual Note 10 - Basic and Diluted Net Loss Per Share (Details Textual) Details http://www.compasstherapeutics.com/20260331/role/statement-note-10-basic-and-diluted-net-loss-per-share-tables 44 false false R45.htm 995470 - Disclosure - Note 10 - Basic and Diluted Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-10-basic-and-diluted-net-loss-per-share-schedule-of-antidilutive-securities-excluded-from-computation-of-earnings-per-share-details Note 10 - Basic and Diluted Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Details 45 false false R46.htm 995471 - Disclosure - Note 11 - License, Research and Collaboration Agreements (Details Textual) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-11-license-research-and-collaboration-agreements-details-textual Note 11 - License, Research and Collaboration Agreements (Details Textual) Details http://www.compasstherapeutics.com/20260331/role/statement-note-11-license-research-and-collaboration-agreements 46 false false R47.htm 995472 - Disclosure - Note 12 - Segment Information (Details Textual) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-12-segment-information-details-textual Note 12 - Segment Information (Details Textual) Details http://www.compasstherapeutics.com/20260331/role/statement-note-12-segment-information-tables 47 false false R48.htm 995473 - Disclosure - Note 12 - Segment Information - Schedule of Segment Reporting Information (Details) Sheet http://www.compasstherapeutics.com/20260331/role/statement-note-12-segment-information-schedule-of-segment-reporting-information-details Note 12 - Segment Information - Schedule of Segment Reporting Information (Details) Details 48 false false All Reports Book All Reports cmpx-20260331.xsd cmpx-20260331_cal.xml cmpx-20260331_def.xml cmpx-20260331_lab.xml cmpx-20260331_pre.xml cmpx20260331_10q.htm http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ecd/2026 true true